Tetraneuron
Pre-clinicalWe are developing a disruptive gene therapy platform addressing the root causes of neurodegenerative conditions through a unique multifactorial approach
Founded
2018
Focus
RNA & Gene Therapy
About
We are developing a disruptive gene therapy platform addressing the root causes of neurodegenerative conditions through a unique multifactorial approach
Funding History
1Total raised: $1.2M
Seed$1.2MCaixa Capital RiscJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationBarcelona, Spain
StagePre-clinical
Contact
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile